Rick Ryan
Exec Chairman at Apertus Pharmaceuticals
Rick Ryan
Exec Chairman at Apertus Pharmaceuticals
Ballwin, Missouri
Overview
Work Experience
General Partner
2013 - Current
Cultivation Capital Life Sciences provides late seed/Series A venture funding to life science related companies. We are interested in opportunities in Healthcare IT and Services, Medical Devices, Pharmaceutical/Biotech, Biomedical Research Tools/reagents/Diagnostics, .
President
2011
Consulting Services: Strategy and Innovation for Life Science Companies Over 35 years experience in both early stage ventures and Fortune 500 multinational corporations, with expertise in technical development/commercialization, general management & P&L responsibilities, and international scope.
Exec Chairman
2024
API SERVICES Apertus is managed and staffed by highly experienced people with relevant backgrounds with fine chemicals, biotech and pharmaceutics. Let us help you with your API needs. FORMULATION DEVELOPMENT Our team has experience developing sterile injectables, potent fomulations, nasal sprays, DEA regulated products, topical creams, liquids, tablets capsules and suppositories. CONTRACT MANUFACTURING Apertus specializes in manufacturing suppositories, capsule, tablet and topical products. We manufacture small to medium sized batches of prescription drug products in our FDA-inspected Saint Louis facility. ANALYTICAL DEVELOPMENT Our team has experience developing and validating HPLC, GC, wet bench, and dissolution tests for API and drug product release testing. Nearly all of our own release testing is performed in-house.
Chief Executive Officer
2012 - 2024
Vice President, Drug Discovery Business Unit
2006 - 2010
Drug Discovery and Development provides products and services to advance the discovery and development of NCE's and Biopharmaceuticals..
President
1999 - 2006
LINCO was a leader in the development and commercialization of research diagnostic kits (RIA, ELISA and Luminex xMAP platforms). It was acquired in May 2006 by Serologicals. Serologicals was acquired by Millipore in July 2006.
Vice President, Global Commercial Development
1996 - 1998
Responsible for global commercial development of novel vaccines and new products/services to support the Innovoject vaccination system..
Various Dir and Mgr level positions
1982 - 1996
Director International Marketing 1993-1996 Director Strategic Planning 1991-1993 Director Product/Commercial Development 1987-1991 Manager R&D 1982-86